U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118891) titled 'Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause' on July 16.
Brief Summary: The purpose of this study is to evaluate the effects of single and multiple doses of ABCLS635 administered by subcutaneous (SC) injection to healthy men and to postmenopausal women with or without any vasomotor symptoms (VMS) or hot flashes, and to postmenopausal women with moderate to severe VMS associated with menopause.The safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) parameters of ABCL635 will be assessed in all study participants; the effects on frequency and severity of VMS will be assessed in postmenopausal women who...